Magenta Therapeutics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$219.7M
Industry:Biotech
Founded:2016
Lead Investor(s):Casdin Capital
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Magenta Therapeutics's estimated annual revenue is currently $8.5M per year.
  • Magenta Therapeutics received $52.0M in venture funding in April 2018.
  • Magenta Therapeutics's estimated revenue per employee is $105,247
  • Magenta Therapeutics's total funding is $219.7M.

Employee Data

  • Magenta Therapeutics has 81 Employees.
  • Magenta Therapeutics grew their employee count by -4% last year.
  • Magenta Therapeutics currently has 10 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ultivue
$8.7M56-12%N/A
Ohana Bioscienc...
$8.7M5660%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. By creating a platform focused on key areas of transplant medicine, Magenta Therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. Founded by internationally recognized leaders in stem cell transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit www.magentatx.com.

keywords:N/A

81

Number of Employees

$8.5M

Revenue (est)

10

Current Jobs

-4%

Employee Growth %

$219.7M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
William NeeleyHead Of Intellectual PropertyEmail Available
Ganapathy SarmaDirectorEmail Available
Zoran ZdraveskiChief Legal Officer and Corporate SecretaryEmail Available
Christopher WilsonManager, CMC Process AnalyticsEmail Available
Daniel ParkDirector, Legal AffairsEmail Available
Jan PinkasSenior Vice PresidentEmail Available
Greg DwyerSenior Director, Business DevelopmentEmail Available
Haley HowellAssociate Director, Clinical OperationsEmail Available
Veit SchmelmerVice President, Program LeadEmail Available
Jason GardnerCEO, President and CofounderEmail Available

Magenta Therapeutics News

12-Sep-19 - Is Magenta Therapeutics, Inc. (NasdaqGM:MGTA) Generating ...

The FCF Growth of Magenta Therapeutics, Inc. (NasdaqGM:MGTA) is . Free cash flow (FCF) is the cash produced by the company minus ...

12-Sep-19 - 80675 Shares in Magenta Therapeutics Inc (NASDAQ:MGTA ...

Alps Advisors Inc. purchased a new stake in shares of Magenta Therapeutics Inc (NASDAQ:MGTA) during the 2nd quarter, according to its most ...

2019. 9. 12. - Magenta Therapeutics, Inc. (MGTA): Average 1-Day ...

35 days have passed by since the last earnings report for Magenta Therapeutics, Inc. (NASDAQ:MGTA) and the new quarterly results look set ...

Magenta Therapeutics Funding

DateAmountRoundLead InvestorsReference
2016-11-17$48.5MAThird Rock Ventures, LLCArticle
2017-05-03$50.0MBGoogle VenturesArticle
2018-04-10$52.0MCCasdin CapitalArticle

Magenta Therapeutics Executive Hires

DateNameTitleReference
2017-10-27Charlotte McDonaghVP BiotherapeuticsArticle
2018-02-22John DavisChief Medical OfficerArticle
2018-03-09Christina IsacsonChief Business OfficerArticle